AJR Am J Roentgenol

1. MARCUS C
   Editorial Comment: FDG PET/CT Has Impact in CAR T-Cell Therapy Response Assessment and Outcome Prediction.
   AJR Am J Roentgenol. 2023 Dec 20. doi: 10.2214/AJR.23.30703.
   

   >> Share

   
   

   
   Am J Clin Pathol

2. DERNELL C, Astle J, Bogachkov A, Reimer S, et al
   Improving resource utilization: Axillary lymph node core biopsy triaging for lymphoma.
   Am J Clin Pathol. 2024 Apr 9:aqae032. doi: 10.1093.
   

   >> Share

   
   

   
   Am J Hematol

3. CHOQUET S, Soussain C, Azar N, Morel V, et al
   CAR T-cell therapy induces a high rate of prolonged remission in relapsed primary CNS lymphoma: Real-life results of the LOC network.
   Am J Hematol. 2024 Apr 8. doi: 10.1002/ajh.27316.
   

   >> Share

   
   
4. MOU E, Fernandez-Pol S, Li S, Rieger KE, et al
   Clinical characteristics, treatment patterns, and outcomes of cytotoxic cutaneous T-cell lymphomas.
   Am J Hematol. 2024;99:985-988.
   

   >> Share

   
   

   
   Am J Surg Pathol

5. COTTA CV, Bhavsar S, Robertson S, Cook JR, et al
   Patients with Classic Hodgkin Lymphoma and Follicular Lymphoma Compared to Single Malignancy Controls.
   Am J Surg Pathol. 2024 Apr 11. doi: 10.1097/PAS.0000000000002225.
   

   >> Share

   
   

   
   Blood

6. MERLIO JP
   Staphylococcus aureus and Sezary syndrome.
   Blood. 2024;143:1436-1438.
   

   >> Share

   
   
7. WEI Q, Bueso-Ramos CE
   Thymoma with aberrant expression of CD20: a potential diagnostic pitfall of B-cell lymphoma.
   Blood. 2024;143:1551.
   

   >> Share

   
   
8. KROEZE E, Iaccarino I, Kleisman MM, Mondal M, et al
   Mutational and transcriptional landscape of pediatric B-cell precursor lymphoblastic lymphoma.
   Blood. 2024 Apr 8:blood.2024023938. doi: 10.1182/blood.2024023938.
   

   >> Share

   
   
9. VADIVEL CK, Willerslev-Olsen A, Namini MRJ, Zeng Z, et al
   Staphylococcus aureus induces drug resistance in cancer T cells in Sezary syndrome.
   Blood. 2024;143:1496-1512.
   

   >> Share

   
   

   
   BMC Cancer

10. SUN H, Shang J, Liu X, Ren S, et al
    Eukaryotic initiation factor 3a promotes the development of diffuse large B-cell lymphoma through regulating cell proliferation.
    BMC Cancer. 2024;24:432.
    

    >> Share

    
    

    
    Br J Dermatol

11. BLANCHARD M, Morren MA, Busschots AM, Hauben E, et al
    Paediatric onset lymphomatoid papulosis: results of a multicentre retrospective cohort study, on behalf of the EORTC Cutaneous Lymphoma Tumours Group (CLTG).
    Br J Dermatol. 2024 Apr 10:ljae150. doi: 10.1093.
    

    >> Share

    
    

    
    Br J Haematol

12. MOULIN C, Beaupain B, Suarez F, Bertrand Y, et al
    CXCR4 WHIM syndrome is a cancer predisposition condition for virus-induced malignancies.
    Br J Haematol. 2024;204:1383-1392.
    

    >> Share

    
    
13. BOMMANNAN K, Arumugam JR, Radhakrishnan V, Sundersingh S, et al
    Relevance of CD20 antigen expression among paediatric patients with B-lineage acute lymphoblastic leukaemia.
    Br J Haematol. 2024;204:1367-1374.
    

    >> Share

    
    
14. MARTYNCHYK A, Hawkes EA
    Learnings from phosphatidylinositol 3-kinase inhibitors in lymphoma-Moving to a model where less can be more.
    Br J Haematol. 2024 Apr 6. doi: 10.1111/bjh.19456.
    

    >> Share

    
    
15. KUHNL A, Roddie C, Kirkwood AA, Chaganti S, et al
    Outcome and feasibility of radiotherapy bridging in large B-cell lymphoma patients receiving CD19 CAR T in the UK.
    Br J Haematol. 2024 Apr 9. doi: 10.1111/bjh.19453.
    

    >> Share

    
    

    
    J Am Acad Dermatol

16. HASAN I, Parsons L, Duran S, Zinn Z, et al
    Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: a retrospective cohort study.
    J Am Acad Dermatol. 2024 Apr 6:S0190-9622(24)00566.
    

    >> Share

    
    
17. POWERS CM, Piontkowski AJ, Orloff J, Pulsinelli J, et al
    Risk of lymphoma in patients with atopic dermatitis: A case-control study in the All of Us database.
    J Am Acad Dermatol. 2024 Apr 4:S0190-9622(24)00554.
    

    >> Share

    
    

    
    Leuk Lymphoma

18. SANCHO JM, Abrisqueta P, Kumar A, Cordoba R, et al
    Safety and efficacy of parsaclisib in combination with rituximab, bendamustine + rituximab, or ibrutinib in patients with previously treated B-cell lymphoma: analysis of a phase 1 dose-finding study (CITADEL?112).
    Leuk Lymphoma. 2024 Apr 10:1-11. doi: 10.1080/10428194.2024.2331626.
    

    >> Share

    
    
19. SCHAFF L, Nayak L, Grommes C
    Bruton's tyrosine kinase (BTK) inhibitors for the treatment of primary central nervous system lymphoma (PCNSL): current progress and latest advances.
    Leuk Lymphoma. 2024 Apr 10:1-13. doi: 10.1080/10428194.2024.2333985.
    

    >> Share

    
    

    
    Leukemia

20. DELROCCO NJ, Loh ML, Borowitz MJ, Gupta S, et al
    Enhanced Risk Stratification for Children and Young Adults with B-Cell Acute Lymphoblastic Leukemia: A Children's Oncology Group Report.
    Leukemia. 2024 Feb 15. doi: 10.1038/s41375-024-02166.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

21. MAROUI MA, Odongo GA, Mundo L, Manara F, et al
    Aflatoxin B1 and Epstein-Barr virus-induced CCL22 expression stimulates B cell infection.
    Proc Natl Acad Sci U S A. 2024;121:e2314426121.
    

    >> Share

    
    
22. KRISTENSON L, Badami C, Ljungberg A, Islamagic E, et al
    Deletion of the TMEM30A gene enables leukemic cell evasion of NK cell cytotoxicity.
    Proc Natl Acad Sci U S A. 2024;121:e2316447121.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share